Literature DB >> 376921

Growth of normal and malignant human mammary epithelial cells in culture.

W L Kirkland, N S Yang, T Jorgensen, C Longley, P Furmanski.   

Abstract

Normal and malignant human mammary epithelial cells were placed in culture. Normal cells were recovered from late-lactation milk and breast fluids, and malignant cells were isolated from primary breast tumors by collagenase digestion. The concentration of cells obtained from breast fluid samples was inversely proportional to the volume of fluid secreted. Most of these cells adhered rapidly to the substrate, did not replicate, displayed Fc receptor-dependent phagocytic activity, and were thus identified as macrophages. The remaining cells grew out into large islands comprised of one or two distinct morphologic types of mammary epithelial cells. Optimum growth of these cells was obtained in medium buffered to pH 6.8, and the epidermal growth factor markedly prolonged the exponential growth phase of the cells. Two morphologically distinct populations of epithelial cells were also observed in cultures established from individual breast tumors. Growth of the malignant cells was relatively unaffected by the pH of the culture medium, and the cells were unresponsive to exogenously added hormones. Overgrowth of malignant epithelial cells in primary cultures by stromal fibroblasts was retarded by replacement of standard growth medium with fresh medium containing a serum substitute; growth of the malignant epithelial cells was unaffected. A feeder layer of mitomycin C-treated human fibroblasts increased the plating efficiency of both normal and malignant cells in primary culture and also facilitated passage of these cells to secondary and tertiary cultures.

Entities:  

Mesh:

Year:  1979        PMID: 376921

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  16 in total

1.  A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.

Authors:  P Briand; O W Petersen; B Van Deurs
Journal:  In Vitro Cell Dev Biol       Date:  1987-03

2.  Transient promoter activity in primary rat mammary epithelial cells evaluated using particle bombardment gene transfer.

Authors:  T A Thompson; M N Gould; J K Burkholder; N S Yang
Journal:  In Vitro Cell Dev Biol       Date:  1993-02

3.  Effect of the extracellular matrix on plasminogen activator isozyme activities of human mammary epithelial cells in culture.

Authors:  N S Yang; C Park; C Longley; P Furmanski
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

4.  Sustained growth in primary culture of normal mammary epithelial cells embedded in collagen gels.

Authors:  J Yang; J Richards; R Guzman; W Imagawa; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

5.  Growth of normal human mammary cells in culture.

Authors:  M Stampfer; R C Hallowes; A J Hackett
Journal:  In Vitro       Date:  1980-05

6.  Epidermal growth factor receptor expression, proliferation, and colony stimulating activity production in the urinary bladder carcinoma cell line 5637.

Authors:  M Häder; D Stach-Machado; K H Pflüger; M Rotsch; B Heimann; K Moelling; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 7.  Stem cells and the development of mammary cancers in experimental rats and in humans.

Authors:  P S Rudland
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

8.  Development of a new human breast cancer cell line Ia-270.

Authors:  P M Loh; G Clamon; J MacIndoe; M White; L Urdaneta; B Hukku; W D Peterson
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

9.  Long-term proliferation of mouse thymic epithelial cells in culture.

Authors:  U K Ehmann; R A Shiurba; W D Peterson
Journal:  In Vitro Cell Dev Biol       Date:  1986-12

10.  Cultures of exfoliated mammary epithelial cells: variation between donors.

Authors:  M Stoker; M Perryman
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.